| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.0063 | 0.9 |
| mRNA | TPCA-1 | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | MS-275 | GDSC1000 | pan-cancer | AAC | -0.0095 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | Bryostatin 1 | GDSC1000 | pan-cancer | AAC | -0.0061 | 0.9 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.9 |
| mRNA | BRD-K19103580 | CTRPv2 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | serdemetan | FIMM | pan-cancer | AAC | 0.026 | 0.9 |
| mRNA | CAL-101 | CTRPv2 | pan-cancer | AAC | 0.006 | 0.9 |
| mRNA | IPA-3 | GDSC1000 | pan-cancer | AAC | 0.0054 | 0.9 |